作者
Jennifer Cable,Eilika Weber‐Ban,Tim Clausen,Kylie J. Walters,Michal Sharon,Daniel Finley,Yangnan Gu,John Hanna,Yue Feng,Sascha Martens,Anne Simonsen,Malene Hansen,Hong Zhang,Jonathan M. Goodwin,Alessio Reggio,Chunmei Chang,Liang Ge,Brenda Schulman,Raymond J. Deshaies,Ivan Đikić,J. Wade Harper,Ingrid E. Wertz,Nicolas H. Thomä,Mikołaj Słabicki,Judith Frydman,Ursula Jakob,Della David,Eric J. Bennett,Carolyn R. Bertozzi,Richa Sardana,Vinay V. Eapen,Serena Carra
摘要
Abstract Targeted protein degradation is critical for proper cellular function and development. Protein degradation pathways, such as the ubiquitin proteasomes system, autophagy, and endosome–lysosome pathway, must be tightly regulated to ensure proper elimination of misfolded and aggregated proteins and regulate changing protein levels during cellular differentiation, while ensuring that normal proteins remain unscathed. Protein degradation pathways have also garnered interest as a means to selectively eliminate target proteins that may be difficult to inhibit via other mechanisms. On June 7 and 8, 2021, several experts in protein degradation pathways met virtually for the Keystone eSymposium “Targeting protein degradation: from small molecules to complex organelles.” The event brought together researchers working in different protein degradation pathways in an effort to begin to develop a holistic, integrated vision of protein degradation that incorporates all the major pathways to understand how changes in them can lead to disease pathology and, alternatively, how they can be leveraged for novel therapeutics.